NCT07390539 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT07390539
Title	B7-H3.CD28Z.CART in CNS Neoplasms
Recruitment	Not yet recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Robbie Majzner
Indications	high grade ependymoma atypical teratoid rhabdoid tumor medulloblastoma embryonal tumor with multilayered rosettes pineoblastoma spinal cord ependymoma brain ependymoma
Therapies	Cyclophosphamide + Fludarabine B7-H3.CD28Z.CAR-T cells
Age Groups:	adult \| child
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
Boston Children's Hospital		Boston	Massachusetts	02115	United States	Details
Dana-Farber Cancer Institute		Boston	Massachusetts	02215	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT07390539Clinical Trial Detail